anti-angiogenic therapy
Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme
13
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
58
Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy
16
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
17
Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions
24
Inhibition of endoplasmic reticulum chaperone protein glucose- regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway
13
Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
11
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline : implications for optimizing anti angiogenic therapy
18
Recent Advances in Anti-Angiogenic Therapy of Cancer
13
Role of Anti Angiogenic Therapy in Prevention of Recurrence in Hormonal Positive Breast Cancer: A Secondary Prevention Strategy and Method of Therapy
7
Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy
8
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
83
Deciphering the anti angiogenic effect of endostatin/cyclophosphamide to normalize tumor micrangium through notch signaling pathway in colon cancer
8
Future options of anti-angiogenic cancer therapy
9
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab
9
Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
8
<p>Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging</p>
13
Comparison of anti angiogenic properties of pristine carbon nanoparticles
8
Briefly about Anticancer Properties of Statins
5
The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia
12